Brand Name Prescription Drug Pricing
Kessler Topaz Meltzer & Check, LLP is Investigating Potential Claims on Behalf of Certain Brand Name Prescription Drug Purchasers
Kessler Topaz Meltzer & Check, LLP (“Kessler Topaz”) is investigating a potential class action lawsuit against certain health insurance companies.
Specifically, Kessler Topaz is investigating a potential class action lawsuit on behalf of certain patients who were forced by insurance providers, and other potential entities, to purchase high cost, brand name drugs instead of cheaper, generic versions.
The drugs currently being investigated include:
| Adderall XR | (ADD or ADHD) | |
| Aggrenox | (Stroke) | |
| Copaxone | (MS) | |
| Invega | (Schizophrenia) | |
| Remicade | (Crohns, Arthritis) | |
| Voltaren | (Inflammation) | |
| Zetia | (Cholesterol) |
If you or someone you know was forced to purchase any of the drugs listed above instead of paying for less expensive generic alternatives, and would like to learn more about our investigation, please fill out our online form, or contact us today at 888-299-7706 or by email at [email protected]
Free Consultation Request